Palomino Laboratories (PALX) Free Cash Flow (2023 - 2025)

Palomino Laboratories (PALX) reported Free Cash Flow of -$343500.0 for Q3 2025, down 1189.47% on a YoY basis from $31529.0 in Q3 2024, and down 582.29% sequentially from -$50345.0 in Q2 2025.

Palomino Laboratories (PALX) Free Cash Flow (2023 - 2025) Analysis & Trends

Palomino Laboratories (PALX) has 3 years of Free Cash Flow data on file, last reported at -$343500.0 in Q3 2025.

  • For the quarter ending Q3 2025, Free Cash Flow fell 1189.47% year-over-year to -$343500.0; the trailing twelve-month figure through Dec 2025 stood at -$390793.0 (down 187.48% YoY), and the FY2024 full-year result was -$166637.0, down 109.93% from the prior year.
  • Free Cash Flow declined to -$343500.0 in Q3 2025, from -$50345.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $31529.0 in Q3 2024 to a low of -$343500.0 in Q3 2025.
  • A 3-year average of -$97249.5 and a median of -$53555.5 in 2023 frame the typical range for Free Cash Flow.
  • Across the five-year window, Free Cash Flow slumped 195.01% in 2024 and plunged 1189.47% in 2025, its largest moves.
  • Tracing PALX's Free Cash Flow over 3 years: stood at -$56766.0 in 2023, then tumbled by 195.01% to -$167467.0 in 2024, then tumbled by 105.12% to -$343500.0 in 2025.
  • Business Quant data shows PALX's Free Cash Flow at -$343500.0 in Q3 2025, -$50345.0 in Q2 2025, and $3052.0 in Q1 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Sep 30, 2025 -343,500.00
Sep 30, 2025 -343,500.00
Jun 30, 2025 -50,345.00
Jun 30, 2025 -50,345.00
Mar 31, 2025 3,052.00
Mar 31, 2025 3,052.00
Dec 31, 2024 -167,467.00
Dec 31, 2024 -167,467.00
Sep 30, 2024 31,529.00
Sep 30, 2024 31,529.00
Dec 31, 2023 -56,766.00
Dec 31, 2023 -56,766.00